BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

TRIUS THERAPEUTICS — Lobbying — Receipts Report

LD-2 disclosure · Registration

TRIUS THERAPEUTICS

via FABIANI & COMPANY

2nd Quarter (Apr 1 - June 30) · 2008Posted May 1, 2008Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: TRIUS THERAPEUTICS
Description: Pharmaceutical Development
Location: California · United States of America

Registrant

Firm: FABIANI & COMPANY
Description: Global trade
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Antibiotics, BioDefense
Lobbyistsms WENDY SHELTON dvm · mr JAMES P FABIANI · DANIELLE ORGAN PETERS

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.